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Abstract 
Primary colorectal signet ring cell carcinoma (SRCC) is a rare but distinctive type of 
mucin-producing adenocarcinoma of the large intestine with still controversial 
clinicopathological features and prognosis. We encountered primary colonic SRCC in a 
51-year-old Japanese man with extensive bone metastasis ultimately leading to 
carcinocythemia before the initiation of chemotherapy and surgical intervention. Three 
days before death, besides progressive disseminated intravascular coagulation that had 
been present on admission, hematological examination showed sudden leukocytosis 
with nonhematopoietic cells that subsequently turned out to be signet ring cells (SRCs). 
Carcinocythemia, the presence of circulating cancer cells in peripheral blood, is 
considered to be a rare but an ominous phenomenon occurring in the advanced stage of 
certain types of cancers, particularly mammary lobular carcinoma. It can be assumed that 
carcinoma cells lacking intercellular cohesiveness and polarized cell membrane 
organization, including SRCs as well as lobular carcinoma cells, can readily get access to 
the peripheral circulation; however, to our knowledge, this is the first report of primary 
colorectal SRCC that presented carcinocythemia. Extensive bone metastatic sites, in the 
present case, may have functioned as a reservoir of circulating SRCs. 
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Introduction 
Primary colorectal signet ring cell carcinoma (SRCC), first described by Laufman and 
Saphir in 1951 [1], is a rare but distinctive histological type of colorectal adenocarcinoma 
that accounts for less than 1% of all colorectal malignancies [2–4]. SRCC is a 
mucin-producing adenocarcinoma whose cells retain intracytoplasmic mucin, pushing 
their nuclei to the periphery [4]. Signet ring cells (SRCs) may be arranged solely or in 
loose clusters and may spread diffusely through the colorectal wall [3]. Since the vast 
majority of SRCCs arise in the stomach with the rest arising from other organs, including 
the colon, rectum, gallbladder, pancreas, urinary bladder, and breast [5], metastatic 
SRCCs must be excluded before making the definite diagnosis of primary colorectal 
SRCC. It is of little doubt that primary colorectal SRCC has a poor prognosis; however, 
most studies so far have demonstrated controversial results for clinicopathological 
features and prognosis of primary colorectal SRCC [2–4, 6, 7], partly because of the 
limited number of cases with this type of colorectal carcinoma. Hence, more studies and 
reports should be accumulated to more accurately characterize the biological behaviors of 
primary colorectal SRCC. We report here an autopsy case of primary colonic SRCC with 
extensive bone metastasis, ultimately leading to carcinocythemia before the initiation of 
chemotherapy and surgical intervention. The mechanisms underlying such a unique 
metastatic process will be discussed along with other hematologic and coagulative 
abnormalities observed in the present case. 
Case Report 
A 51-year-old Japanese man visited with a complaint of severe back pain. In spite of no apparent 
abnormal findings in lumbar roentgenogram, magnetic resonance imaging (MRI) demonstrated high 
signal intensity spreading diffusely in multiple vertebrae, suggesting a diffuse bone metastasis that may 
also simulate multiple myeloma, leukemia, myelodysplastic syndrome, and osteomyelitis (fig. 1a). To 
determine the possible primary lesion, systemic computed tomography (CT) scanning was performed, 
which detected a mass lesion in the ascending colon (fig. 1b). Subsequent colonoscopic examination 
revealed a type 3 tumor (fig. 1c), and histopathological examination of the biopsied specimen disclosed 
SRCC. Since additional endoscopic examination could not detect any cancerous lesion in the stomach, 
which is the most common site of SRCC, we diagnosed the colonic tumor as primary colonic SRCC. 
At the same time, hematological examination showed mild thrombocytopenia (12.9 × 10
4/μl) 
(fig. 2a), hypofibrinogenemia (952 μg/ml), and elevated fibrin/fibrinogen degradation products 
(69.4 μg/ml) and D-dimer (61.5 μg/ml) (fig. 2b), which were, as a whole, suggestive of disseminated 
intravascular coagulation. Elevated levels of serum alkaline phosphatase (ALP) (750 IU/l) and lactate 
dehydrogenase (LDH) (1,226 IU/l) (fig. 2c), in addition to carcinoembryonic antigen (21.1 ng/ml) and 
carbohydrate antigen 19-9 (79.3 U/ml), were also detected. Considering possible future chemotherapy, 
heparin and gabexate mesilate were administered; however, the patient’s clinical condition rapidly 
deteriorated without any chance for chemotherapy. On the 22nd day after admission, hematological 
examination showed sudden leukocytosis (25,200/μl) (fig. 2d) with approximately 1% of 
nonhematopoietic cells in addition to abrupt elevation of serum ALP (1,085 IU/l), LDH (4,769 IU/l) 
(fig. 2c), and C-reactive protein (CRP) (23.4 μg/ml) levels (fig. 2d). Subsequent cytological examination 
disclosed that those nonhematopoietic cells (fig. 3a) harbored periodic acid-Schiff (PAS)-positive mucin 
inside the cells (fig. 3b) and were also positive for cytokeratin (CK) CAM5.2 (Becton Dickinson, San 
Jose, CA, USA) (fig. 3c) [8], indicating these cells were SRCs originating from the colonic tumor. The 
patient died of multiple organ failure on the 25th day after admission. 
Postmortem examination restricted to abdominal organs was carried out with permission. 
Macroscopically, the colonic tumor was a whitish ulcerative type 3 tumor, measuring 50 × 35 mm, 
invading predominantly the subserosa and adjacent mesenteric lymph nodes, and disseminated to the 
peritoneal cavity to form multiple whitish nodules up to 3 mm in diameter. Apparent macrometastases 
were not detected in other visceral organs such as liver, spleen, and kidneys.  
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Histologically, the colonic tumor consisted of a diffuse infiltration with frequent lymphatic invasion 
of SRCs (fig. 3d) harboring abundant Alcian blue (AB)- or PAS-positive mucin pushing their nuclei to 
the periphery (fig. 3e), and diffusely spread throughout the colonic wall with predominance of 
subserosa. Distant metastasis was detected in lumbar vertebrae, whose marrow cavity was almost 
exclusively occupied with SRCs (fig. 3f). Interestingly, while apparent tumors or nodules were not 
detected in the liver, numbers of SRCs infiltrated hepatic sinusoids, mimicking leukemic infiltration 
without any alteration of the hepatic parenchyma (fig. 3g). A small number of SRCs was detected in the 
marginal sinus of the spleen as well. In addition to the fact that precise histological examination of the 
stomach failed to detect any primary gastric SRCC, colonic SRCs were immunohistochemically positive 
for CDX2 (CDX2-88; BioGenex, San Ramon, CA, USA) (fig. 3h) [9], negative for CK 7 (OV-TL 12/30; 
Dako, Kyoto, Japan) (fig. 3i), focally positive for CK 20 (Ks20.8; Dako) (fig. 3j) [10], positive for MUC2 
(Ccp58; Novocastra, Newcastle upon Tyne, UK) (fig. 3k), and focally positive for MUC5AC (CLH2; 
Novocastra) (fig. 3l) [11, 12]. These findings combined allowed us to diagnose the colonic tumor as 
primary colonic SRCC. 
Discussion 
In spite of controversial results for clinicopathological features and prognosis [2–4, 
6, 7], primary colorectal SRCC is generally considered to have a poor prognosis partly due 
to its (i) diffuse intramural infiltration, (ii) lymph node involvement, and (iii) peritoneal 
dissemination, and therefore (iv) advanced disease (stage III or IV) at the time of 
diagnosis and (v) lower rate of curative resection [5, 12]. 
To exclude metastatic SRCC from other organs, particularly that of the stomach, we 
performed immunohistochemistry for a battery of antigens besides precise histological 
examination of the stomach, which failed to detect any primary gastric SRCC. CDX2, a 
homeodomain protein involved in the regulation of intestinal development and 
differentiation, is expressed in the nuclei of epithelial cells throughout the intestine and 
has been demonstrated in all cases of colorectal adenocarcinomas and almost 50% of 
gastric adenocarcinomas [9]. The CK 7(–)/CK 20(+) profile of the carcinoma cells favors 
the colorectal neoplasms rather than those arising in the stomach, pancreatobiliary tract, 
breast, and prostate [10]. Additionally, among the mucin core proteins, MUC2 and 
MUC5AC are expressed in the intestinal and gastric mucosa, respectively [11]. In the 
present case, some population of the SRCs exhibited an aberrant expression of MUC5AC, 
which implied a phenotypic diversity of mucin-secreting tumors. 
We report here an autopsy case of primary colonic SRCC characterized by the 
occurrence of carcinocythemia in the terminal stage. Three days before death, 
hematological examination showed sudden leukocytosis with nonhematopoietic cells that 
subsequently turned out to be SRCs. It should be argued whether the SRCs could directly 
permeate into the peripheral circulation from the primary site. In this case, the lymphatic 
invasion was more pronounced than vascular invasion in the colonic tumor. Even though 
a certain number of SRCs may transiently circulate in the peripheral blood, such tumor 
cells may be destroyed by natural killer cells or other tumor-specific cytotoxic response, 
or may escape from the circulation to form metastatic tumors in the distant organs. 
Excess in population of the tumor cells in the bone marrow overwhelming the capacity of 
reticuloendothelial clearance can flood into the peripheral circulation at the terminal 
stage of cancer [13]. 
In this case, it can be assumed that the bone metastatic sites behave as a reservoir of 
circulating SRCs. Colonic SRCs may find a way to metastasize to the distant site via the 
lymphatic or hematogenous pathways, then migrate and colonize in the bone marrow 
sinus, where the SRCs occupy the sinusoidal space from which the cancer cells flood into 
the peripheral circulation. Carcinocythemia, a term introduced by Carey et al. in 1976  
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[14], is known as a unique form of cancer metastasis in which the cancer cells can be 
detected in the peripheral blood, generally occurring in far advanced stage of certain 
malignant neoplasms such as breast cancer, small cell carcinoma, and rhabdomyosarcoma 
[15]. In particular, it is noteworthy that mammary lobular carcinoma has a potential 
propensity for bone metastasis and subsequent carcinocythemia [13]. Carcinoma cells 
lacking intercellular cohesiveness and polarized cell membrane organization, including 
SRCs as well as lobular carcinoma cells, can readily get access to the peripheral 
circulation; however, as far as we know, this is the first report of colorectal SRCC that 
presented carcinocythemia. 
In conclusion, we report an autopsy case of primary colonic SRCC with extensive bone 
metastasis, ultimately leading to carcinocythemia with disseminated intravascular 
coagulation, which deprived us of any chance for chemotherapy and surgical 
intervention. Carcinocythemia, the presence of circulating tumor cells, is considered to be 
a rare but an ominous phenomenon occurring in the advanced stage of cancers, including 
the present case. 
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Fig. 1. a MRI showing high signal intensity spreading diffusely in multiple vertebrae. b Systemic CT 
scanning showing a mass lesion in the ascending colon. c Colonoscopic examination revealing a type 3 
tumor in the ascending colon. 
 
 
  
Case Rep Gastroenterol 2008;2:301–307 
DOI: 10.1159/000155146 
Published online: September 30, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
305
Fig. 2. Hematological examination during the course of the disease showing mild thrombocytopenia 
(a), hypofibrinogenemia and elevated level of D-dimer (b) and elevated levels of serum ALP and LDH 
(c). At the terminal stage, sudden leukocytosis and elevated CRP levels (d) with abrupt elevation of 
serum ALP and LDH (c) were observed. 
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Fig. 3. a–c Cytological examination demonstrating nonhematopoietic cells in peripheral blood. 
Nonhematopoietic cells in peripheral blood appear in lose clusters (a, PAP staining), having 
PAS-positive mucin inside the cells pushing their nuclei to the periphery (b, PAS staining). They are 
immunocytochemically positive for CK CAM5.2 (c). d–l Histopathology of the specimen obtained at 
postmortem examination. The colonic tumor consists of a diffuse infiltration with occasional lymphatic 
invasion (arrowheads) of SRCs (d, HE staining) harboring abundant AB- or PAS-positive mucin inside 
the cells (e, AB-PAS staining). Bone marrow cavities of the lumbar vertebrae are almost exclusively 
occupied by the SRCs positive for CK AE1/AE3 (Dako) (f). AB-positive SRCs infiltrate hepatic 
sinusoids without any alteration of the hepatic parenchyma (g, AB-PAS staining). The colonic SRCs are 
immunohistochemically positive for CDX2 (h), negative for CK 7 (i), focally positive for CK 20 (j), 
positive for MUC2 (k), and focally positive for MUC5AC (l). Bar = 10 μm for a–c and 20 μm for d–l. 
PAP = Papanicolaou; HE = hematoxylin and eosin. 
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